Skip to content
healthcare.dev

Mesalamine

NDC 0378-1375, mesalamine, capsule, extended release, from Mylan Pharmaceuticals Inc..

Product NDC
0378-1375
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207271
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-1375 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE.375 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
0378-1375-7800378137578120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-1375-78)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c8b93ea3-0367-4605-b87f-06c3812ff3b7
  • NADAC price for package 00378137578

    GET /v1/drugs/nadac/00378137578

Use it

Look up 0378-1375 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-1375 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-1375. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.